Glucagon like peptide-1 receptor agonists for the management of obesity and non-alcoholic fatty liver disease: a novel therapeutic option
Gauri Dhir, Kenneth Cusi
DOI: 10.1136/jim-2017-000554 Published 10 January 2018
Gauri Dhir
1
Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA
2
Division of Endocrinology, Diabetes and Metabolism, Malcom Randall VA Medical Center, Gainesville, Florida, USA
Kenneth Cusi
1
Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA
2
Division of Endocrinology, Diabetes and Metabolism, Malcom Randall VA Medical Center, Gainesville, Florida, USA
Article Figures & Data
Figures
Glucagon like peptide-1 receptor agonists for the management of obesity and non-alcoholic fatty liver disease: a novel therapeutic option
Gauri Dhir, Kenneth Cusi
Journal of Investigative Medicine Jan 2018, 66 (1) 7-10; DOI: 10.1136/jim-2017-000554
Respond to this article